Protein cages as theranostic agent carriers

IFMBE Proceedings

Volumn 39 IFMBE, Issue , 2013, Pages 321-324

  Lim, Sierin ^a   Peng, Tao ^a   Sana, Barindra ^a  

^a Nanyang Technological University   (Singapore)

Author keywords

controlled release; Drug delivery; MRI contrast agent; nanocages; nanocapsules

Indexed keywords

CONTROLLED RELEASE; CONTROLLED RELEASE PROPERTIES; FACILE MODIFICATIONS; MRI CONTRAST AGENTS; NANOCAGES; SMALL-MOLECULE DRUGS; SUBUNIT INTERACTIONS; THERANOSTIC AGENTS;

BIOMEDICAL ENGINEERING; DRUG DELIVERY; LIGANDS; NANOCAPSULES; PHYSICS;

PROTEINS;

EID: 84876056086     PISSN: 16800737     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1007/978-3-642-29305-4_86     Document Type: Conference Paper

References (12)

1. Uchida M, Klem MT, Allen M et al. (2007) Biological Containers: Protein Cages as Multifunctional Nanoplatforms. Adv Mater 19:1025-1042 (Pubitemid 46947996)
2. Dalmau M, Lim S, Chen HC et al. (2008) Thermostability and molecular encapsulation within an engineered caged protein scaffold. Biotechnol Bioeng 101:654-664
3. Ren D, Kratz F, Wang SW (2011) Protein nanocapsules containing doxorubicin as a pH-responsive delivery system. Small 7:1051-1060
4. The PyMOL Molecular Graphics System, Version 1.3, Schrödinger, LLC.
5. Kratz F, Warnecke A, Scheuermann K et al. (2002) Probing the cysteine-34 position of endogenous serum albumin with thiol-binding doxorubicin derivatives. Improved efficacy of an acid-sensitive doxorubicin derivative with specific albumin-binding properties compared to that of the parent compound. J Med Chem 45:5523-33 (Pubitemid 35424970)
6. Ding C, Gu J, Qu X, Yang Z (2009) Preparation of multifunctional drug carrier for tumor-specific uptake and enhanced intracellular delivery through the conjugation of weak acid labile linker. Bioconjug Chem 20:1163-70
7. Dalmau M, Lim S, Wang SW (2009) Design of a pH-dependent molecular switch in a caged protein platform. Nano Lett 9:160-166
8. Peng T, Lim S (2011) Trimer-based design of pH-responsive protein cage results in soluble disassembled structures. Biomacromolecules 12:3131-3138
9. Sana B, Johnson E, Sheah K et al. (2010) Iron-based ferritin nanocore as a contrast agent. Biointerphases 5:FA48-FA52
10. Sana B, Poh CL, Lim S (2012) A manganese-ferritin nanocomposite as an ultrasensitive T2 contrast agent. Chem Commun 48:862-864
11. Ruoslahti E, Bhatia SN, Sailor MJ (2010) Targeting of drugs and nanoparticles to tumors. J Cell Biol 188:759-68
12. Aina OH, Sroka TC, Chen ML, Lam KS (2002) Therapeutic cancer targeting peptides. Biopolymers. 66:184-99 (Pubitemid 35285218)